LFTD Partners Inc. LSFP OTC

LFTD Partners Inc. (LSFP) reported total assets of $19.27T and total liabilities of $6.64T for fiscal year 2025, resulting in total equity of $12.63T.

The company held $1.77T in cash and short-term investments. Total debt stood at $1.76T, with net debt of $-9.26B. The Debt-to-Equity (D/E) ratio was 0.14 (conservative).

Current ratio is 3.04, indicating strong short-term liquidity. Interest coverage is 3.2x (adequate).

Criteria supported by this page:

• HEALTH (83/100, Pass) — Debt-to-Equity of 0.14, current ratio of 3.04, interest coverage 3.2x — balance sheet is strong
• MOAT (52/100) — Total assets $19.27T and equity $12.63T support the company's competitive scale

Overall SharesGrow Score: 43/100 with 1/7 criteria passed.

LLY

Eli Lilly and Company

$922.50

-0.76%

JNJ

Johnson & Johnson

$240.10

+0.90%

ABBV

AbbVie Inc.

$210.32

+1.86%

RHHBF

Roche Holding AG

$418.50

+1.82%

RHHBY

Roche Holding AG

$51.02

+0.65%

AZN

AstraZeneca PLC

$204.38

+1.06%

NVSEF

Novartis AG

$156.48

+0.00%

MRK

Merck & Co., Inc.

$119.96

-0.16%